-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Acenocoumarol-d4 is an anti-coagulant drug that is used to prevent blood clots from forming.
It is commonly used in patients who have artificial heart valves, atrial fibrillation, or other conditions that increase the risk of blood clots.
The drug works by inhibiting the action of vitamin K-dependent coagulation factors, which are proteins that play a crucial role in blood clotting.
In the chemical industry, Acenocoumarol-d4 is used as an intermediate in the production of other chemicals and drugs.
The upstream products of Acenocoumarol-d4 are the raw materials that are used to manufacture the drug, while the downstream products are the final products that are derived from the drug.
One of the upstream products of Acenocoumarol-d4 is coumarin, which is a naturally-occurring compound that is found in various plants, including the tonka bean.
Coumarin is used as a precursor in the synthesis of Acenocoumarol-d4, and it is converted into the drug through a series of chemical reactions.
Another upstream product of Acenocoumarol-d4 is 4-hydroxycoumarin, which is also used in the synthesis of the drug.
4-hydroxycoumarin is synthesized by hydroxylating coumarin, and it is then converted into Acenocoumarol-d4 through a series of chemical reactions.
In addition to coumarin and 4-hydroxycoumarin, Acenocoumarol-d4 is also derived from other upstream products, such as benzene, nitrogen, and hydrochloric acid.
These raw materials are used in the production of the drug through a series of chemical reactions that involve the addition of functional groups, the formation of ring structures, and the condensation of various chemicals.
Once Acenocoumarol-d4 has been synthesized, it is used as a raw material in the production of downstream products.
One of the most common downstream products of Acenocoumarol-d4 is warfarin, which is another anti-coagulant drug that is commonly used to prevent blood clots.
Warfarin is synthesized by adding an electrophilic group to Acenocoumarol-d4, which results in the formation of a new compound that has a different chemical structure but similar anti-coagulant properties.
Another downstream product of Acenocoumarol-d4 is the anticoagulant rodenticide difenacoum, which is used to control rodent populations in agricultural and urban settings.
Difenacoum is synthesized by adding a second electrophilic group to Acenocoumarol-d4, which results in the formation of a new compound that has a different chemical structure but similar anticoagulant properties.
In addition to warfarin and difenacoum, Acenocoumarol-d4 is also used as a raw material in the production of other downstream products, such as a variety of drugs, pesticides, and other chemicals.
The drug is also used in research and development, where it is studied for its potential therapeutic effects on various diseases, including cancer, Alzheimer's disease, and others.
In conclusion, Acenocoumarol-d4 is an important intermediate in the production of various chemicals and drugs.
The upstream products of the drug include coumarin, 4-hydroxycoumarin, benzene, nitrogen, and hydrochloric acid, among others.
These raw materials are used in the production of the drug through a series of chemical reactions that involve the addition of functional groups, the formation of ring structures, and the condensation of various chemicals.
The downstream products of Acenocoumarol-d4 include warfarin, difenacoum, and other anticoagulant drugs, as well as a variety of other chemicals and drugs.
These products are used in a variety of applications, including the treatment of blood clots, the control of rodent populations, and the development of new drugs